Contrast Sensitivity and Optical Quality of the Eye after Instillation of Timolol Maleate Gel-Forming Solution and Brinzolamide Ophthalmic Suspension.
Summary of "Contrast Sensitivity and Optical Quality of the Eye after Instillation of Timolol Maleate Gel-Forming Solution and Brinzolamide Ophthalmic Suspension."
To investigate the influence of timolol maleate 0.5% gel-forming solution and brinzolamide 1% ophthalmic suspension on contrast sensitivity, ocular higher-order aberration (HOA), and corneal surface light scattering.
Prospective, comparative study.
Forty normal volunteers were enrolled in this study.
We evaluated contrast sensitivity, ocular HOA, and corneal light scattering before and 2, 5, 10, and 15 minutes after instillation of antiglaucoma eyedrops. Contrast sensitivity function was assessed with the CSV-1000RN chart (Vector Vision Co., Greenville, OH). Higher-order aberration was measured for a 4-mm pupil using the Hartmann-Shack aberrometer (KR-9000PW; Topcon, Tokyo, Japan). Corneal surface light scattering was quantitatively evaluated by using the Scheimpflug camera (EAS-1000, Nidek, Aichi, Japan). MAIN OUTCOME
Time course of changes in contrast sensitivity, ocular HOAs, and corneal light scattering.
Both timolol gel-forming solution and brinzolamide significantly decreased contrast sensitivity for at least 5 minutes after instillation (P<0.01). There were no significant differences in contrast sensitivity between the drugs at any time points. Higher-order aberration, such as third- and fourth-order aberrations and total HOAs, significantly increased after instillation of each drug (P<0.001). Timolol gel-forming solution significantly increased HOA up to 5 minutes after instillation (P<0.05), whereas brinzolamide significantly increased HOA for at least 2 minutes after instillation (P<0.001). Corneal surface scattering significantly increased for 5 minutes after instillation of brinzolamide (P<0.01), but not after instillation of timolol gel-forming solution.
Both drugs temporarily deteriorate contrast sensitivity function and optical quality of the eye. However, the mechanism underlying contrast sensitivity reduction seems to be different between the drugs. The reduction may be mainly attributed to increased HOA after instillation of timolol gel and increased light scattering after instillation of brinzolamide. FINANCIAL DISCLOSURE(S): The authors have no proprietary or commercial interest in any materials discussed in this article.
This article was published in the following journal.
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/20656353
- DOI: http://dx.doi.org/10.1016/j.ophtha.2010.03.028
Medical and Biotech [MESH] Definitions
A beta-adrenergic antagonist similar in action to PROPRANOLOL. The levo-isomer is the more active. Timolol has been proposed as an antihypertensive, antiarrhythmic, antiangina, and antiglaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor.
Radiographic examination of the process of defecation after the instillation of a CONTRAST MEDIA into the rectum.
Products or parts of products used to detect, manipulate, or analyze light, such as LENSES, refractors, mirrors, filters, prisms, and OPTICAL FIBERS.
Cholangiopancreatography, Magnetic Resonance
Non-invasive diagnostic technique for visualizing the PANCREATIC DUCTS and BILE DUCTS without the use of injected CONTRAST MEDIA or x-ray. MRI scans provide excellent sensitivity for duct dilatation, biliary stricture, and intraductal abnormalities.
The ability to detect sharp boundaries (stimuli) and to detect slight changes in luminance at regions without distinct contours. Psychophysical measurements of this visual function are used to evaluate visual acuity and to detect eye disease.
Increased intraocular pressure (IOP) is significant risk factor for the development of glaucoma. Timolol Maleate is a beta adrenergic receptor blocking agent and it is used for the treatment of glauco...
PURPOSE: To evaluate the effects of brimonidine 0.2%-timolol 0.5% fixed-combination therapy in the treatment of patients with glaucoma. METHODS: To measure the main treatment effects of a fixed combin...
AimThe aim of this study is to compare the 24-hour efficacy of dorzolamide/timolol-fixed combination (DTFC) and brimonidine/timolol-fixed combination (BTFC) in primary open-angle glaucoma (POAG).Metho...
PURPOSE: To compare the ocular hypotensive effect of bimatoprost plus timolol and travoprost plus timolol fixed combinations in glaucoma patients whose disease was controlled but had not reached their...
PURPOSE: To assess the effects of brimonidine and of brimonidine and timolol fixed combination (BTFC) therapy on the pupil and angle structures in both normal subjects and in open angle glaucoma patie...
This study compares patient symptoms and anterior segment safety in patients treated with timilol hemihydrate, generic timolol gel forming solution or timolol maleate.
To assess the safety and efficacy of a cohort of patients switched to the dorzolamide/timolol maleate fixed combination because they are insufficiently controlled on latanoprost monotherap...
This study is comparing 2 medications for glaucoma and how effective they are at controlling glaucoma over the course of an entire day.
The objective of the study is to evaluate whether timolol hemihydrate is more comfortable upon instillation than timolol maleate in sorbate.
This study compares the efficacy and tolerability/comfort of brimonidine/timolol and dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension. In an investigator ma...